Cyclacel pharmaceuticals, inc. (CYCC)
Balance Sheet / Yearly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Dec'10
Condensed Balance Sheet Statement [Table]
ASSETS
Current assets:
Cash and cash equivalents

8,900

11,885

12,967

15,159

17,934

17,504

18,973

19,824

21,725

23,910

26,025

13,591

12,729

16,520

18,029

15,931

17,115

20,440

22,728

26,902

29,363

24,189

26,707

33,456

28,154

31,146

34,487

33,668

14,139

16,412

17,837

19,964

23,640

24,449

27,675

20,614

29,495

Inventory

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

50

109

-

165

147

174

Prepaid expenses and other current assets

2,888

2,132

2,869

2,991

2,190

2,283

1,696

2,863

3,007

2,064

1,792

2,460

4,305

3,097

4,521

2,762

4,120

4,126

3,966

3,453

5,514

4,640

4,202

3,422

4,718

3,388

2,440

2,670

2,056

1,599

1,235

1,639

1,423

1,069

-

-

1,382

Current assets of discontinued operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

29

75

75

-

100

124

147

171

267

403

580

639

792

817

835

861

881

-

-

313

-

-

-

Prepaid expenses and other current assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

941

1,688

-

Total current assets

11,811

14,017

15,836

18,150

20,124

19,787

20,669

22,687

24,732

25,974

27,817

16,051

17,034

19,617

22,579

18,768

21,310

24,566

26,794

30,479

35,024

29,000

31,176

37,281

33,452

35,173

37,719

37,155

17,030

18,872

19,953

21,653

25,172

25,831

28,781

22,449

31,051

Property and equipment, net

25

27

28

29

33

36

38

43

45

29

34

32

39

45

73

109

151

198

255

309

333

387

454

305

285

275

174

169

184

129

140

149

166

167

165

246

408

Right-of-use lease asset

1,151

1,264

1,213

1,285

1,353

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Long-term assets of discontinued operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Long-term assets of discontinued operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

72

-

-

-

-

-

-

-

-

-

-

-

Long-term assets of discontinued operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

24

-

-

-

-

-

-

-

-

-

-

-

-

-

Long-term assets of discontinued operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

48

-

96

186

272

353

433

-

-

-

-

-

-

Total assets

12,987

15,308

17,077

19,464

21,510

19,823

20,707

22,730

24,777

26,003

27,851

16,083

17,073

19,662

22,652

18,877

21,461

24,764

27,049

30,788

35,357

29,387

31,630

37,610

33,785

35,520

37,989

37,510

17,486

19,354

20,526

21,802

25,338

25,998

28,946

22,695

31,459

LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable

250

890

887

1,106

1,284

2,719

1,411

1,675

1,949

1,558

1,973

2,038

1,652

2,497

1,979

1,898

1,582

1,940

1,616

2,609

4,007

2,792

2,201

4,543

4,719

2,545

2,352

2,437

2,825

2,259

1,642

1,544

1,116

1,717

1,101

1,104

1,723

Accrued and other current liabilities

1,273

1,530

1,184

1,394

1,203

1,732

2,592

2,319

2,309

2,555

2,292

2,281

2,476

2,762

3,562

3,592

3,739

3,813

3,572

3,806

4,054

4,626

4,490

3,095

3,811

4,431

6,284

3,797

3,534

5,601

4,127

4,174

4,504

4,183

4,797

4,459

4,132

Current liabilities of discontinued operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

29

75

75

-

75

75

75

75

75

145

260

260

322

325

323

335

438

-

-

527

-

-

-

Total current liabilities

1,523

2,420

2,071

2,500

2,487

4,451

4,003

3,994

4,258

4,113

4,265

4,319

4,128

5,259

5,570

5,565

5,396

5,753

5,263

6,490

8,136

7,493

6,766

7,783

8,810

7,256

8,978

6,579

7,252

9,335

7,297

6,746

6,802

6,498

5,935

6,040

6,535

Lease liability

1,073

1,191

1,154

1,233

1,468

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other liabilities

-

-

-

-

-

100

-

-

-

-

-

-

-

130

-

-

-

176

-

-

-

206

-

-

-

241

-

-

-

-

-

-

-

-

-

-

-

Economic Rights measured at fair value

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

550

1,120

1,070

1,007

1,153

-

37

477

680

Other liabilities

-

-

-

-

-

-

106

112

124

124

128

128

127

-

141

150

-

-

-

-

-

0

-

0

20

20

20

20

20

20

20

21

29

71

-

-

-

Other liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

166

-

186

198

192

-

221

238

-

-

-

-

-

-

-

-

-

-

-

-

-

Total liabilities

2,596

3,611

3,225

3,733

3,955

4,551

4,109

4,106

4,382

4,237

4,393

4,447

4,255

5,389

5,711

5,715

5,562

5,929

5,449

6,688

8,328

7,699

6,987

8,021

8,810

7,497

8,978

6,579

7,252

9,335

7,297

6,746

6,802

6,498

5,935

6,040

6,535

Commitments and contingencies (Notes 3 and 9)

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

-

-

-

0

-

-

0

Stockholders' equity:
Preferred stock, value

-

-

-

-

-

-

0

0

0

-

-

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

-

-

-

1

1

1

1

1

1

1

1

Common stock, $0.001 par value; 100,000,000 shares authorized at December 31, 2019 and March 31, 2020; 859,998 and 859,998 shares issued and outstanding at December 31, 2019 and March 31, 2020.

1

1

17

17

17

12

12

12

12

12

12

4

4

4

4

3

35

3

34

34

34

23

23

23

20

19

18

17

11

9

8

59

59

8

55

47

47

Additional paid-in capital

370,183

370,142

370,071

369,944

369,958

365,817

365,160

365,123

365,086

365,057

364,843

351,148

350,156

350,051

349,897

343,150

342,815

342,587

341,891

341,530

341,415

330,962

328,943

328,774

319,355

317,543

315,036

311,125

292,114

280,211

278,655

278,514

278,430

276,498

276,312

266,529

266,666

Accumulated other comprehensive loss

-946

-819

-913

-808

-781

-760

-796

-801

-846

-794

-762

-736

-748

-743

-760

-737

-662

-596

-540

-388

-691

-480

-305

-97

-101

-109

-172

-5

-193

48

51

78

65

57

49

39

31

Accumulated deficit

-358,847

-357,627

-355,323

-353,422

-351,639

-349,797

-347,778

-345,710

-343,857

-342,509

-340,635

-338,780

-336,594

-335,039

-332,200

-329,254

-326,289

-323,159

-319,785

-317,076

-313,729

-308,817

-304,018

-299,111

-294,299

-289,430

-285,871

-280,206

-281,698

-270,250

-265,486

-263,596

-260,019

-257,064

-253,406

-249,961

-241,821

Total stockholders' equity

10,391

11,697

13,852

15,731

17,555

15,272

16,598

18,624

20,395

21,766

23,458

11,636

12,818

14,273

16,941

13,162

15,899

18,835

21,600

24,100

27,029

21,688

24,643

29,589

24,975

28,023

29,011

30,931

10,234

10,019

13,229

15,056

18,536

19,500

23,011

16,655

24,924

Total liabilities and stockholders' equity

12,987

15,308

17,077

19,464

21,510

19,823

20,707

22,730

24,777

26,003

27,851

16,083

17,073

19,662

22,652

18,877

21,461

24,764

27,049

30,788

35,357

29,387

31,630

37,610

33,785

35,520

37,989

37,510

17,486

19,354

20,526

21,802

25,338

25,998

28,946

22,695

31,459